All 17 members removed from advisory panel, with RFJ Jr claiming it is “plagued with conflict of interest.”

The challenges of developing optimized biologics formulations are well known, but the good news is that the industry continues to develop solutions.

We explore how AI-based tools are making a mark in formulation by improving solubility.

A glimpse into the research of one of the most prevalent gastrointestinal disorders worldwide, and how small molecule drug development is helping.

Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.

The IQVIA Institute’s latest report evaluates how well seven countries are prepared to support the complex infrastructure required for CAR T therapies

Is the complexity of the fill-finish process under appreciated in pharma manufacturing? Four experts discuss why it’s important to get it right.